Synapse - Vincent Miller

Results (64)

Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene

Journal Article

Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

Journal Article

Paik, P. K.; Arcila, M. E.; Fara, M.; Sima, C. S.; Miller, V. A.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation

Journal Article

Oxnard, G. R.; Arcila, M. E.; Sima, C. S.; Riely, G. J.; Chmielecki, J.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Incidence of EGFR Exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas

Journal Article

D'Angelo, S. P.; Pietanza, M. C.; Johnson, M. L.; Riely, G. J.; Miller, V. A.; Sima, C. S.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR

Journal Article

Bivona, T. G.; Hieronymus, H.; Parker, J.; Chang, K.; Taron, M.; Rosell, R.; Moonsamy, P.; Dahlman, K.; Miller, V. A.; Costa, C.; more...
Nature (2011)

Fulltext@MSK | Save

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay

Journal Article

Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)

Meeting Abstract

Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

EGFR mutations in men and cigarette smokers with lung adenocarcinoma

Meeting Abstract

Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: A preliminary report

Journal Article

Girard, N.; Lou, E.; Azzoli, C. G.; Reddy, R.; Robson, M.; Harlan, M.; Orlow, I.; Yatabe, Y.; Nafa, K.; Ladanyi, M.; more...
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Rebiopsy of patients (pts) with acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)

Meeting Abstract

Arcila, M. E.; Riely, G. J.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Miller, V. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save